BAY |
News
- FDA accepts Dupixent® (dupilumab) for review in children with moderate-to-severe asthma
07:00 - GlobeNewswire - Sprott Focus Trust, Inc. (Nasdaq-FUND) Declares First Quarter Common Stock Distribution of $0.1044 Per Share
03/03/2021 / 23:00 - GlobeNewswire - W&T Offshore Announces Fourth Quarter and Full Year 2020 Results Including Year-End 2020 Proved Reserves and Provides 2021 Guidance
03/03/2021 / 22:52 - GlobeNewswire - PMV Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Highlights
03/03/2021 / 22:01 - GlobeNewswire - The Royal Merges Sustainability and Luxury
03/03/2021 / 19:32 - GlobeNewswire - Schneider outlines ongoing commitment to a sustainable future
03/03/2021 / 16:55 - GlobeNewswire - CRISPR Therapeutics to Participate in Upcoming Investor Conferences
03/03/2021 / 14:00 - GlobeNewswire - Ekso Bionics Teams Up with Performance Contracting, Inc. for Innovative Testing Approach of EVO™ Technology
03/03/2021 / 14:00 - GlobeNewswire - PTA-DD: Bayer Aktiengesellschaft: Managers' transactions announcement according to article 19 MAR
03/03/2021 / 10:00 - pressetext - PTA-DD: Bayer Aktiengesellschaft: Managers' transactions announcement according to article 19 MAR
03/03/2021 / 10:00 - pressetext - PTA-DD: Bayer Aktiengesellschaft: Managers' transactions announcement according to article 19 MAR
03/03/2021 / 10:00 - pressetext - PTA-DD: Bayer Aktiengesellschaft: Managers' transactions announcement according to article 19 MAR
03/03/2021 / 10:00 - pressetext - PTA-DD: Bayer Aktiengesellschaft: Managers' transactions announcement according to article 19 MAR
03/03/2021 / 10:00 - pressetext - PTA-DD: Bayer Aktiengesellschaft: Managers' transactions announcement according to article 19 MAR
03/03/2021 / 10:00 - pressetext - PTA-DD: Bayer Aktiengesellschaft: Managers' transactions announcement according to article 19 MAR
03/03/2021 / 10:00 - pressetext